Are thyroid peroxidase antibodies a marker of Hashimoto’s disease?

Thyroid peroxidase (TPO) antibodies are widely recognized as the primary diagnostic biomarker for autoimmune thyroiditis, specifically Hashimoto’s disease. In clinical practice, these antibodies serve as a reliable indicator of the immune system's involvement in thyroid dysfunction, particularly when assessing patients with unexplained hypothyroidism or goiter.

Clinical evidence

Research consistently identifies TPO antibodies as a hallmark of Hashimoto’s thyroiditis, appearing in 90% to 95% of affected individuals.

• Diagnostic Accuracy: Studies report a sensitivity ranging from 89.7% to 92% and a specificity between 91% and 94.8% for diagnosing autoimmune thyroiditis.
• Predictive Value: The presence of these antibodies is a strong predictor of progression from subclinical to overt hypothyroidism. Patients who are TPO-antibody positive have a significantly higher risk of developing clinical thyroid failure over time compared to those who are antibody negative.
• Standard of Care: Clinical guidelines recommend TPO antibody testing to confirm thyroid autoimmunity when ultrasound reveals characteristic hypoechoic or heterogeneous thyroid tissue patterns.

Mechanistic explanations

The role of TPO antibodies extends beyond simple markers; they are intrinsically linked to the pathophysiology of thyroid destruction.

• Enzymatic Interference: Thyroid peroxidase is an enzyme essential for the synthesis of thyroid hormones. The immune system generates antibodies—primarily of the IgG1 subclass—that target this enzyme.
• Cellular Destruction: This immune response triggers antibody-dependent cell-mediated cytotoxicity (ADCC). This process leads to the activation of immune cells that cause thyrocyte necrosis and apoptosis (programmed cell death).
• Tissue Transformation: Chronic lymphocytic infiltration resulting from this immune response causes the progressive destruction of thyroid follicles. This leads to the fibrosis and increased thyroid stiffness typically observed in Hashimoto’s disease.

Bottom line

TPO antibodies are a highly sensitive and specific marker for Hashimoto’s disease, reflecting the underlying autoimmune destruction of thyroid tissue. Their presence confirms the autoimmune origin of thyroid dysfunction and predicts the future risk of overt hypothyroidism.